BIOTON S.A. (WSE:BIO)

Poland flag Poland · Delayed Price · Currency is PLN
4.170
-0.010 (-0.24%)
Apr 28, 2026, 5:00 PM CET
11.20%
Market Cap 358.91M
Revenue (ttm) 282.52M
Net Income (ttm) 3.39M
Shares Out 85.86M
EPS (ttm) 0.04
PE Ratio 105.82
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 22,702
Average Volume 17,820
Open 4.180
Previous Close 4.180
Day's Range 4.100 - 4.180
52-Week Range 3.650 - 4.700
Beta 0.23
RSI 46.28
Earnings Date Apr 29, 2026

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 364
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.